Skip to content

The AMD Experts

teamphoto

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to create AMD Centers of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize is that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Article: May 2020 | Women in Optometry

Theia Overcomes AMD Standard Of Care Challenges

"Open yourself up to learning something new. Education truly is the key to being a trailblazer," says Frances Bynum, OD in her latest piece dedicated to conquering the challenges ODs face with subclinical AMD detection.

Article: May 2020 | Optometric Management

Knowledge Center: Age-Related Macular Degeneration

The AdaptDx Pro is truly a revolutionary way to quickly and effectively measure dark adaptation (to help detect subclinical AMD) in virtually any setting, without taking up too much staff or doctor time.

Article: May 1, 2020 | Optometric Management Magazine

Diagnostic Focus: Measuring Adaptation to Dark

The AdaptDx Pro is unique because it is a head-mounted testing device. It also has an onboard instruction voice named Theia that walks the patient through the testing.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.